A wave of glucose management is developing with the introduction of rapidly dissolving GLP-1 type agonists. These advanced formulations remove the necessity for injections, offering a potentially more user-friendly alternative for individuals struggling with glucose 2 glucose. This breakthrough promises better person compliance and could considerab